Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 24
Phase 31
Phase 45

Trial Status

Completed9
Other2

Role Distribution

Principal Investigator10
Other Roles1
PI Rate91%

Activity Timeline

Clinical Trials (11)

NCT02700334Phase 4Completed
Effect of Dapagliflozin on Insulin Secretion and Insulin Sensitivity in Patients With Prediabetes
Impaired Fasting GlucoseImpaired Glucose TolerancePrediabetes
PrincipalinvestigatorStart date: 2016-10-01
NCT03006471Phase 4Completed
Effect of Dapagliflozin on Blood Pressure Variability in Prediabetes and Prehypertension
PreDiabetesPrehypertension
PrincipalinvestigatorStart date: 2016-03-30
NCT02354339Not ApplicableCompleted
Effect of Irvingia Gabonensis Administration on Metabolic Syndrome, Insulin Secretion and Insulin Sensitivity
Metabolic Syndrome X
PrincipalinvestigatorStart date: 2015-01-01
NCT02330341Not ApplicableCompleted
Effect of Artemisia Dracunculus on Glucose Intolerance, Insulin Sensitivity and Insulin Secretion
Glucose Intolerance
PrincipalinvestigatorStart date: 2014-12-01
NCT02113241Phase 2/3Completed
Effect of Dapagliflozin Administration on Metabolic Syndrome, Insulin Sensitivity, and Insulin Secretion
Metabolic Syndrome X
PrincipalinvestigatorStart date: 2014-04-01

Showing 10 of 11 trials

Research Network

Collaboration Network

4 collaborators·5 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

ali ismail, lecturer

Cairo University

Related
29 trials

Shared therapeutic areas:

Metabolic SyndromeDiabetes Mellitus, Type 2Hypertension+1 more
Similarity Score17%

David Crowley, MD

KGK Science Inc.

Related
54 trials

Shared therapeutic areas:

HypertensionPrediabetic StateDiabetes Mellitus, Type 2+1 more
Similarity Score17%

Esperanza Martínez, PHD

University of Guadalajara

Related
2 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 2

Worked with same sponsors:

Laboratorios Silanes S.A. de C.V.
Collaborated on 1 trial
Similarity Score14%

Jorge A González, MD

Laboratorios Silanes S.A. de C.V.

Related
2 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 2

Worked with same sponsors:

Laboratorios Silanes S.A. de C.V.
Collaborated on 1 trial
Similarity Score14%

Samuel Klein, MD

Washington University School of Medicine

Related
30 trials

Shared therapeutic areas:

Metabolic SyndromeDiabetes Mellitus, Type 2Prediabetic State
Similarity Score13%

Ali MA Ismail, lecturer

Cairo University

Related
27 trials

Shared therapeutic areas:

Metabolic SyndromePrediabetic State
Similarity Score9%

Glen P Kenny, PhD

University of Ottawa

Related
18 trials

Shared therapeutic areas:

HypertensionDiabetes Mellitus, Type 2
Similarity Score9%

Jack A Yanovski, M.D.

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Related
23 trials

Shared therapeutic areas:

HypertensionGlucose Intolerance
Similarity Score9%

Adrian Vella, MD

Mayo Clinic

Related
19 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 2Prediabetic State
Similarity Score9%

Britt Burton-Freeman, ph.D

Illinois Institute of Technology

Related
23 trials

Shared therapeutic areas:

Glucose IntolerancePrediabetic State
Similarity Score9%

Publications (0)

No publications found for this investigator.

Clinical Trials (11)

Showing 11 of 11 trials

NCT03592667Phase 4PrincipalInvestigator

Dapagliflozin on Blood Pressure Variability and Ambulatory Arterial Stiffness Index in Hypertension

Hypertension
Unknown
NCT03444142Phase 4PrincipalInvestigator

Effect of Exenatide LAR or Dulaglutide on the Variability of 24-hour Heart Rate and Blood Pressure in Type 2 Diabetes

Diabetes Mellitus, Type 2
Unknown
NCT02700334Phase 4PrincipalInvestigator

Effect of Dapagliflozin on Insulin Secretion and Insulin Sensitivity in Patients With Prediabetes

Impaired Fasting GlucoseImpaired Glucose TolerancePrediabetes
Completed
NCT03006471Phase 4PrincipalInvestigator

Effect of Dapagliflozin on Blood Pressure Variability in Prediabetes and Prehypertension

PreDiabetesPrehypertension
Completed
NCT02354339Not ApplicablePrincipalInvestigator

Effect of Irvingia Gabonensis Administration on Metabolic Syndrome, Insulin Secretion and Insulin Sensitivity

Metabolic Syndrome X
Completed
NCT02330341Not ApplicablePrincipalInvestigator

Effect of Artemisia Dracunculus on Glucose Intolerance, Insulin Sensitivity and Insulin Secretion

Glucose Intolerance
Completed
NCT02113241Phase 2/3PrincipalInvestigator

Effect of Dapagliflozin Administration on Metabolic Syndrome, Insulin Sensitivity, and Insulin Secretion

Metabolic Syndrome X
Completed
NCT00940797Phase 2StudyChair

Effect of DMMET-01 on Insulin Sensitivity in Naive Type 2 Diabetes Patients (CLAMP)

Diabetes Type 2
Completed
NCT02114892Phase 2PrincipalInvestigator

Effect of Resveratrol Administration on Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion

Metabolic Syndrome X
Completed
NCT02680457Phase 4PrincipalInvestigator

Effect of Insulin Degludec Versus Insulin Glargine on Glycemic Variability in Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus
Completed
NCT02767869Phase 2PrincipalInvestigator

Effect of Banaba (Lagerstroemia Speciosa) on Metabolic Syndrome, Insulin Secretion and Insulin Sensitivity

Metabolic Syndrome X
Completed

All 11 trials loaded